A Study to Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

NCT06360094 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

85

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

Idiopathic Pulmonary Fibrosis
Progressive Pulmonary Fibrosis

Interventions

DRUG: BI 1839100
DRUG: Placebo

Sponsor

Boehringer Ingelheim